Retension Pharmaceuticals, Inc. · NASDAQ:RTSN
B Group, Inc. reported a 10.00% stake in Retension Pharmaceuticals, Inc. (Schedule 13G)
Event Oct 13, 2026 · Filed Oct 16, 2026
B Group, Inc. reported a 10.00% stake in Retension Pharmaceuticals, Inc., 833,333 shares, as a passive investor on Oct 13, 2026. Filed Oct 16, 2026 (Schedule 13G).
- Stake
- 10.00%
- Shares
- 833,333
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| The B Group, Inc. | 10.00% | 833,333 |
| B Group Capital LLC | 10.00% | 833,333 |
| Branden B. Muhl | 10.00% | 833,333 |
Source
Download original · View original at SEC
Related
- Retension Pharmaceuticals, Inc.
- B Group, Inc.
- Retension Pharmaceuticals, Inc. shareholders
- Schedule 13G · Pvg Asset Management Corp · Oct 16, 2026
- Schedule 13G · Laurence W. Lytton · Oct 15, 2026
- Schedule 13D · Eric Keller · Oct 14, 2026
- Form 4 · Berendt Michael J · Oct 13, 2026
- Form 4 · Berger Franklin M · Oct 13, 2026